Commentary on the Trial of Antihypertensive Interventions and Management (TAIM) Study.
Kaplan
N M
NM
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D001262:Atenolol / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002752:Chlorthalidone / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D015431:Weight Loss / Q000187:drug effects / Q000502:physiology
D000959:Antihypertensive Agents; D001262:Atenolol; D002752:Chlorthalidone